MetLife (MET) Tops Q1 EPS by 17c, Misses on Revenue
Tweet
Share
E-mail
Get Alerts MET Hot Sheet
Price: $97.62 -1.62%
Revenue Growth %: +15.8%
Financial Fact:
Policyholder benefits and claims: 10.86B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.8%
Financial Fact:
Policyholder benefits and claims: 10.86B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
MetLife (NYSE: MET) reported Q1 EPS of $2.42, $0.17 better than the analyst estimate of $2.25. Revenue for the quarter came in at $19.07 billion versus the consensus estimate of $19.43 billion.
For earnings history and earnings-related data on MetLife (MET) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Computacenter Plc. (CCC:LN) PT Raised to GBP60 at JPMorgan
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
